Zhongbing Qi

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy.

DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 09, 2025

Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study.

Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study.

Journal: Carcinogenesis

Published: April 16, 2025

Blockade of metastasis by targeting circulating tumor cells with platelet encapsuled oncolytic adenovirus.

Blockade of metastasis by targeting circulating tumor cells with platelet encapsuled oncolytic adenovirus.

Journal: Biomaterials

Published: March 20, 2025

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity.

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity.

Journal: Journal for immunotherapy of cancer

Published: November 11, 2024

CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity.

CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity.

Journal: Experimental hematology & oncology

Published: November 11, 2024

Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming.

Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming.

Journal: Frontiers in immunology

Published: October 18, 2024

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.

Journal: Frontiers in immunology

Published: June 30, 2022

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

Journal: Frontiers in oncology

Published: March 16, 2022

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.

Journal: Frontiers in cellular neuroscience

Published: November 21, 2021

Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment.

Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment.

Journal: Human gene therapy

Published: August 18, 2021

Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.

Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.

Journal: Molecular biomedicine

Published: August 08, 2021

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.

Journal: Acta biomaterialia

Published: May 11, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026